Eli Lilly Corp. buy SVB Leerink LLC
Start price
10.11.25
/
50%
€807.50
Target price
10.11.26
€955.18
Performance (%)
31.62%
Price
14:27
€1,062.8
Summary
This prediction is currently active. With a performance of 31.62% the BUY prediction by SVB_Leerink_LLC is a big success. This prediction currently runs until 10.11.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 0.703% | 0.703% |
| iShares Core DAX® | -0.874% | 5.325% |
| iShares Nasdaq 100 | -0.381% | 1.979% |
| iShares Nikkei 225® | -1.676% | 1.952% |
| iShares S&P 500 | -0.655% | 2.069% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $1,104.00 price target on the stock, up previously from $886.00.
Ratings data for LLY provided by MarketBeat